News & Updates

SG’s cramped migrant worker dorms prone to COVID-19 outbreaks
SG’s cramped migrant worker dorms prone to COVID-19 outbreaks
03 Feb 2022
Reaction patterns may aid in diagnosis of COVID-19 vaccine-related cutaneous side effects
Reaction patterns may aid in diagnosis of COVID-19 vaccine-related cutaneous side effects
02 Feb 2022 byStephen Padilla

A registry-based study has recently shown diverse COVID-19 vaccine-associated dermatologic reactions, including papulovesicular, pityriasis rosea-like, and papulosquamous eruptions classified as vaccine-related eruption of papules and plaques (V-REPP).

Reaction patterns may aid in diagnosis of COVID-19 vaccine-related cutaneous side effects
02 Feb 2022
Tirzepatide regulates metabolites, lipids in T2D
Tirzepatide regulates metabolites, lipids in T2D
02 Feb 2022

Treatment with tirzepatide leads to a reduction in body weight and improvement in glycaemic control in individuals with type 2 diabetes (T2D), reports a study. In addition, it modulates metabolites associated with T2D risk and metabolic dysregulation that is consistent with improved metabolic health.

Tirzepatide regulates metabolites, lipids in T2D
02 Feb 2022
Risk of colorectal cancer mortality after adenoma removal differs by sex
Risk of colorectal cancer mortality after adenoma removal differs by sex
02 Feb 2022

Women appear to be at higher risk of colorectal cancer death following adenoma removal, whereas men are at lower risk, as reported in a recent study.

Risk of colorectal cancer mortality after adenoma removal differs by sex
02 Feb 2022
Waist circumference, not BMI, a good indicator of outcomes in older diabetics
Waist circumference, not BMI, a good indicator of outcomes in older diabetics
02 Feb 2022

In older patients with type 2 diabetes (T2D), use of body mass index (BMI) does not adequately predict clinical outcomes associated with obesity, but waist circumference (WC) appears to be up to the task.

Waist circumference, not BMI, a good indicator of outcomes in older diabetics
02 Feb 2022
Lifestyle interventions ward off mobility disability in prostate cancer patients on ADT
Lifestyle interventions ward off mobility disability in prostate cancer patients on ADT
02 Feb 2022

An exercise and dietary lifestyle intervention regimen leads to better mobility outcomes among prostate cancer patients undergoing androgen deprivation therapy (ADT) as compared with standard-of-care management, a recent study has found. Moreover, social cognitive outcome measures seem to be predictive of such mobility outcomes.

Lifestyle interventions ward off mobility disability in prostate cancer patients on ADT
02 Feb 2022